These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37533127)

  • 21. Scaling and Sustaining Facilitated Telemedicine to Expand Treatment Access Among Underserved Populations: A Qualitative Study.
    Ventuneac A; Dickerson SS; Dharia A; George SJ; Talal AH
    Telemed J E Health; 2023 Dec; 29(12):1862-1869. PubMed ID: 37252770
    [No Abstract]   [Full Text] [Related]  

  • 22. Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection among People Who Inject Drugs.
    Kim RG; McDonell C; McKinney J; Catalli L; Price JC; Morris MD
    Healthcare (Basel); 2024 Mar; 12(7):. PubMed ID: 38610138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-learning commentary: a patient partner perspective in mental health care research.
    Riches L; Ridgway L; Edwards L
    Res Involv Engagem; 2023 Apr; 9(1):24. PubMed ID: 37072880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When "the Cure" Is the Risk: Understanding How Substance Use Affects HIV and HCV in a Layered Risk Environment in San Juan, Puerto Rico.
    Hernández D; Castellón PC; Fernández Y; Torres-Cardona FA; Parish C; Gorshein D; Vargas Vidot J; Miranda de Leon S; Rodriguez A; Santana Bagur J; Feaster DJ; Schackman BR; Metsch LR
    Health Educ Behav; 2017 Oct; 44(5):748-757. PubMed ID: 28891344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing catalyst films of health experiences: an analysis of a robust multi-stakeholder involvement journey.
    Davis S; Pandhi N; Warren B; Grevious N; Crowder M; Ingersoll H; Perry E; Sussman A; Grob R
    Res Involv Engagem; 2022 Jul; 8(1):34. PubMed ID: 35906697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Reaction to Telemedicine for Clinical Management of Hepatitis C Virus Integrated into an Opioid Treatment Program.
    Talal AH; McLeod A; Andrews P; Nieves-McGrath H; Chen Y; Reynolds A; Sylvester C; Dickerson SS; Markatou M; Brown LS
    Telemed J E Health; 2019 Sep; 25(9):791-801. PubMed ID: 30325701
    [No Abstract]   [Full Text] [Related]  

  • 29. Embedding research codesign knowledge and practice: Learnings from researchers in a new research institute in Australia.
    Javanparast S; Robinson S; Kitson A; Arciuli J
    Res Involv Engagem; 2022 Dec; 8(1):71. PubMed ID: 36476374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs.
    Levander XA; Vega TA; Seaman A; Korthuis PT; Englander H
    Int J Drug Policy; 2021 Oct; 96():103356. PubMed ID: 34226111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the impacts of patient engagement on a national health research network: results of a case study of the Chronic Pain Network.
    Tripp L; Richards DP; Daly-Cyr J; Lane T; Linkiewich D; Begley KN; Buckley N; Hudspith M; Poulin P; Abelson J
    Res Involv Engagem; 2023 Aug; 9(1):73. PubMed ID: 37649098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient engagement in a national research network: barriers, facilitators, and impacts.
    Gonzalez M; Ogourtsova T; Zerbo A; Lalonde C; Spurway A; Gavin F; Shikako K; Weiss JA; Majnemer A
    Res Involv Engagem; 2023 Mar; 9(1):7. PubMed ID: 36890591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities.
    Pearce ME; Jongbloed K; Demerais L; MacDonald H; Christian WM; Sharma R; Pick N; Yoshida EM; Spittal PM; Klein MB
    Int J Drug Policy; 2019 Dec; 74():52-61. PubMed ID: 31525640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring how hospitalization can alter hepatitis c virus treatment prioritization and trajectories in people who use drugs: A qualitative analysis.
    Levander XA; Vega TA; Seaman A; Korthuis PT; Englander H
    Subst Abus; 2022; 43(1):245-252. PubMed ID: 34161198
    [No Abstract]   [Full Text] [Related]  

  • 35. Engagement of people with lived experience of dementia advisory group and cross-cutting program: reflections on the first year.
    Snowball E; Fernandez Loughlin R; Eagleson H; Barnett KM; McLellan E; O'Connor D; Kelly C; Thelker C; McGilton KS; Bethell J
    Res Involv Engagem; 2022 Jun; 8(1):28. PubMed ID: 35752841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era.
    Busschots D; Bielen R; Koc ÖM; Heyens L; Dercon E; Verrando R; Janssens F; Van den Bergh L; Van Lint P; Bruckers L; Nevens F; Robaeys G
    BMC Public Health; 2021 Aug; 21(1):1574. PubMed ID: 34416867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs.
    Jordan AE; Perlman DC; Reed J; Smith DJ; Hagan H
    Front Public Health; 2017; 5():348. PubMed ID: 29326922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valuing All Voices: refining a trauma-informed, intersectional and critical reflexive framework for patient engagement in health research using a qualitative descriptive approach.
    Roche P; Shimmin C; Hickes S; Khan M; Sherzoi O; Wicklund E; Lavoie JG; Hardie S; Wittmeier KDM; Sibley KM
    Res Involv Engagem; 2020; 6():42. PubMed ID: 32699647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research led by people who use drugs: centering the expertise of lived experience.
    Salazar ZR; Vincent L; Figgatt MC; Gilbert MK; Dasgupta N
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):70. PubMed ID: 34544478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining how study teams manage different viewpoints and priorities in patient-centered outcomes research: Results of an embedded multiple case study.
    Maurer ME; Hilliard-Boone T; Frazier K; Forsythe L; Mosbacher R; Carman KL
    Health Expect; 2023 Aug; 26(4):1606-1617. PubMed ID: 37254610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.